 Robert Scheinman
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 10 | 2023 | 1003 | 1.730 |
Why?
| | NF-kappa B | 15 | 2010 | 641 | 1.090 |
Why?
| | Arthritis, Experimental | 7 | 2020 | 130 | 0.980 |
Why?
| | Complement System Proteins | 4 | 2023 | 283 | 0.900 |
Why?
| | Nanoparticles | 4 | 2023 | 313 | 0.720 |
Why?
| | T-Lymphocytes | 7 | 2012 | 1737 | 0.580 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2012 | 1140 | 0.580 |
Why?
| | Complement C3 | 5 | 2023 | 188 | 0.560 |
Why?
| | Erythropoietin | 2 | 2008 | 72 | 0.550 |
Why?
| | Complement Activation | 5 | 2023 | 340 | 0.510 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 535 | 0.500 |
Why?
| | Drug Carriers | 2 | 2017 | 112 | 0.500 |
Why?
| | Macrophages | 6 | 2019 | 1263 | 0.490 |
Why?
| | Antirheumatic Agents | 2 | 2020 | 255 | 0.480 |
Why?
| | I-kappa B Proteins | 5 | 2002 | 79 | 0.460 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 3 | 2020 | 24 | 0.440 |
Why?
| | Interferon-gamma | 2 | 2012 | 719 | 0.380 |
Why?
| | STAT1 Transcription Factor | 1 | 2011 | 64 | 0.380 |
Why?
| | Rheumatology | 1 | 2012 | 88 | 0.360 |
Why?
| | Interleukin-2 | 1 | 2012 | 413 | 0.360 |
Why?
| | Apoptosis | 5 | 2020 | 2363 | 0.360 |
Why?
| | Transcription, Genetic | 5 | 2020 | 1313 | 0.350 |
Why?
| | Ferrosoferric Oxide | 3 | 2019 | 25 | 0.350 |
Why?
| | Osteoarthritis | 1 | 2012 | 171 | 0.340 |
Why?
| | Animals | 33 | 2023 | 31709 | 0.320 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 3 | 2020 | 20 | 0.320 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 73 | 0.310 |
Why?
| | Complement Factor D | 2 | 2020 | 26 | 0.300 |
Why?
| | Liposomes | 3 | 2019 | 146 | 0.300 |
Why?
| | Doxorubicin | 3 | 2019 | 285 | 0.300 |
Why?
| | Fibrosarcoma | 1 | 2008 | 20 | 0.300 |
Why?
| | Dexamethasone | 4 | 2000 | 317 | 0.290 |
Why?
| | Butyrates | 1 | 2008 | 53 | 0.280 |
Why?
| | N-Acetyllactosamine Synthase | 1 | 2007 | 1 | 0.280 |
Why?
| | Protein Modification, Translational | 1 | 2007 | 1 | 0.280 |
Why?
| | Coenzymes | 1 | 2007 | 16 | 0.280 |
Why?
| | Signal Transduction | 8 | 2020 | 4516 | 0.280 |
Why?
| | Protein Engineering | 1 | 2008 | 98 | 0.280 |
Why?
| | Receptors, Glucocorticoid | 2 | 2000 | 130 | 0.270 |
Why?
| | Manganese | 1 | 2007 | 55 | 0.270 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1314 | 0.270 |
Why?
| | Lymphocyte Activation | 3 | 2004 | 1037 | 0.250 |
Why?
| | GTP-Binding Proteins | 1 | 2006 | 139 | 0.250 |
Why?
| | Mice | 19 | 2023 | 14872 | 0.250 |
Why?
| | Nuclear Matrix | 1 | 2005 | 5 | 0.250 |
Why?
| | Receptors, Complement 3b | 2 | 2023 | 81 | 0.230 |
Why?
| | Transcription Factor AP-1 | 3 | 2000 | 80 | 0.230 |
Why?
| | Transcription Factors | 3 | 2005 | 1528 | 0.220 |
Why?
| | Amino Acids | 1 | 2007 | 448 | 0.220 |
Why?
| | Cells, Cultured | 10 | 2020 | 3886 | 0.210 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 352 | 0.210 |
Why?
| | Receptors, Complement 3d | 1 | 2023 | 130 | 0.210 |
Why?
| | Models, Biological | 2 | 2019 | 1621 | 0.200 |
Why?
| | Blood-Retinal Barrier | 2 | 2012 | 13 | 0.200 |
Why?
| | Mitogens | 2 | 1999 | 58 | 0.200 |
Why?
| | Rats | 10 | 2023 | 4958 | 0.200 |
Why?
| | Lectins | 2 | 2019 | 42 | 0.180 |
Why?
| | Single-Chain Antibodies | 1 | 2020 | 14 | 0.180 |
Why?
| | Synoviocytes | 1 | 2020 | 10 | 0.180 |
Why?
| | Repressor Proteins | 2 | 2019 | 366 | 0.180 |
Why?
| | Joints | 1 | 2020 | 84 | 0.170 |
Why?
| | Complement Inactivating Agents | 1 | 2020 | 41 | 0.170 |
Why?
| | Scavenger Receptors, Class A | 1 | 2019 | 9 | 0.170 |
Why?
| | Leukocytes | 2 | 2019 | 276 | 0.170 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 57 | 0.170 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 93 | 0.160 |
Why?
| | Immunoglobulin M | 1 | 2020 | 246 | 0.160 |
Why?
| | CD55 Antigens | 1 | 2019 | 27 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 5 | 2023 | 616 | 0.160 |
Why?
| | Collagen Type II | 1 | 2019 | 48 | 0.160 |
Why?
| | Protein Corona | 1 | 2019 | 5 | 0.160 |
Why?
| | Opsonin Proteins | 1 | 2019 | 25 | 0.160 |
Why?
| | Calcium Phosphates | 1 | 1998 | 24 | 0.160 |
Why?
| | Bone Marrow | 1 | 2020 | 244 | 0.160 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 114 | 0.160 |
Why?
| | RNA Interference | 2 | 2020 | 433 | 0.160 |
Why?
| | Humans | 30 | 2023 | 114709 | 0.160 |
Why?
| | Lymphocytes | 1 | 2020 | 330 | 0.150 |
Why?
| | Immunoglobulins | 1 | 2019 | 143 | 0.150 |
Why?
| | Recombinant Proteins | 4 | 2008 | 1230 | 0.150 |
Why?
| | Intravital Microscopy | 1 | 2017 | 23 | 0.140 |
Why?
| | Biological Transport | 5 | 2020 | 374 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2020 | 2570 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 504 | 0.140 |
Why?
| | Transfection | 5 | 2020 | 866 | 0.140 |
Why?
| | Gene Expression | 3 | 2020 | 1421 | 0.140 |
Why?
| | Dextrans | 1 | 2017 | 73 | 0.140 |
Why?
| | Protein Kinase C | 1 | 1998 | 273 | 0.140 |
Why?
| | Neutrophils | 2 | 2020 | 1176 | 0.140 |
Why?
| | Glycosylation | 2 | 2008 | 130 | 0.140 |
Why?
| | Antibodies | 1 | 2019 | 371 | 0.140 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2017 | 109 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2021 | 1144 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2019 | 477 | 0.130 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 4694 | 0.130 |
Why?
| | Autoantibodies | 1 | 2023 | 1349 | 0.130 |
Why?
| | Bone Marrow Cells | 3 | 2020 | 267 | 0.130 |
Why?
| | Complement C5 | 1 | 2015 | 73 | 0.120 |
Why?
| | Mice, Inbred DBA | 2 | 2020 | 174 | 0.120 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2015 | 53 | 0.120 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2015 | 28 | 0.120 |
Why?
| | Rats, Inbred F344 | 3 | 2004 | 241 | 0.120 |
Why?
| | Drug Delivery Systems | 2 | 2020 | 296 | 0.110 |
Why?
| | Protein Binding | 5 | 2019 | 1890 | 0.110 |
Why?
| | Macromolecular Substances | 3 | 2005 | 200 | 0.110 |
Why?
| | Skin | 1 | 2017 | 655 | 0.110 |
Why?
| | Kinetics | 5 | 2017 | 1551 | 0.110 |
Why?
| | Salicylic Acid | 1 | 2012 | 8 | 0.100 |
Why?
| | Melanins | 1 | 2012 | 17 | 0.100 |
Why?
| | Pigment Epithelium of Eye | 1 | 2012 | 34 | 0.100 |
Why?
| | Chloroquine | 1 | 2012 | 52 | 0.100 |
Why?
| | Enzyme Activation | 2 | 2006 | 785 | 0.100 |
Why?
| | Electric Impedance | 1 | 2012 | 100 | 0.100 |
Why?
| | Sodium Channels | 2 | 1989 | 62 | 0.100 |
Why?
| | Leukostasis | 1 | 2011 | 3 | 0.100 |
Why?
| | Tyrosine | 1 | 2012 | 214 | 0.100 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 43 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 1995 | 646 | 0.090 |
Why?
| | Transcription Factor RelA | 4 | 1995 | 82 | 0.090 |
Why?
| | Drug Stability | 1 | 2011 | 151 | 0.090 |
Why?
| | Macular Edema | 1 | 2011 | 34 | 0.090 |
Why?
| | Retinal Pigment Epithelium | 1 | 2011 | 58 | 0.090 |
Why?
| | Drug Discovery | 1 | 2012 | 123 | 0.090 |
Why?
| | Capillary Permeability | 1 | 2011 | 139 | 0.090 |
Why?
| | NF-KappaB Inhibitor alpha | 4 | 2002 | 52 | 0.090 |
Why?
| | Gene Silencing | 1 | 2011 | 171 | 0.090 |
Why?
| | Chemokine CXCL9 | 1 | 2010 | 21 | 0.090 |
Why?
| | Chemokine CXCL10 | 1 | 2010 | 34 | 0.090 |
Why?
| | Glucocorticoids | 3 | 2000 | 532 | 0.090 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 160 | 0.090 |
Why?
| | Lactic Acid | 1 | 2011 | 275 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2011 | 257 | 0.090 |
Why?
| | Oligopeptides | 1 | 2011 | 236 | 0.090 |
Why?
| | Precipitin Tests | 3 | 2002 | 88 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2008 | 1143 | 0.080 |
Why?
| | Base Sequence | 5 | 2005 | 2114 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2011 | 299 | 0.080 |
Why?
| | Diabetic Retinopathy | 1 | 2011 | 149 | 0.080 |
Why?
| | Cell Line | 5 | 2011 | 2637 | 0.080 |
Why?
| | Polyethylene Glycols | 3 | 2019 | 561 | 0.080 |
Why?
| | Phospholipases A2, Cytosolic | 1 | 2009 | 6 | 0.080 |
Why?
| | Radiation Chimera | 1 | 2009 | 30 | 0.080 |
Why?
| | HeLa Cells | 3 | 1995 | 562 | 0.080 |
Why?
| | Genes | 1 | 1989 | 223 | 0.080 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 25 | 0.080 |
Why?
| | Molecular Sequence Data | 5 | 2005 | 2785 | 0.080 |
Why?
| | Pyrimidines | 1 | 2011 | 376 | 0.080 |
Why?
| | Magnetite Nanoparticles | 2 | 2019 | 28 | 0.080 |
Why?
| | Bone Resorption | 1 | 2009 | 73 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2002 | 430 | 0.080 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2011 | 395 | 0.080 |
Why?
| | Sulfonamides | 1 | 2011 | 445 | 0.070 |
Why?
| | Cell Nucleus | 4 | 2004 | 554 | 0.070 |
Why?
| | Tuberculosis | 1 | 2010 | 241 | 0.070 |
Why?
| | Disease Progression | 2 | 2012 | 2381 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 239 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2010 | 269 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 666 | 0.070 |
Why?
| | Chromosome Mapping | 2 | 2005 | 487 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3535 | 0.070 |
Why?
| | Protein Conformation | 2 | 2019 | 805 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2480 | 0.070 |
Why?
| | Cricetulus | 1 | 2007 | 97 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1879 | 0.070 |
Why?
| | CHO Cells | 1 | 2007 | 138 | 0.070 |
Why?
| | Dogs | 2 | 2021 | 334 | 0.070 |
Why?
| | Cricetinae | 1 | 2007 | 253 | 0.070 |
Why?
| | CD5 Antigens | 1 | 2006 | 8 | 0.070 |
Why?
| | Thymus Gland | 2 | 2005 | 296 | 0.070 |
Why?
| | Rats, Mutant Strains | 1 | 2006 | 25 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 785 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2011 | 951 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2008 | 1842 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2004 | 1019 | 0.060 |
Why?
| | Genes, Synthetic | 1 | 2005 | 14 | 0.060 |
Why?
| | Blotting, Western | 2 | 2011 | 1147 | 0.060 |
Why?
| | Autoantigens | 2 | 2005 | 396 | 0.060 |
Why?
| | RNA, Messenger | 4 | 2015 | 2553 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.060 |
Why?
| | Self Tolerance | 1 | 2005 | 28 | 0.060 |
Why?
| | Tumor Cells, Cultured | 4 | 2002 | 850 | 0.060 |
Why?
| | Zinc Fingers | 1 | 2005 | 43 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2005 | 152 | 0.060 |
Why?
| | Stromal Cells | 1 | 2005 | 97 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 385 | 0.060 |
Why?
| | COS Cells | 1 | 2005 | 175 | 0.060 |
Why?
| | L-Selectin | 1 | 2004 | 25 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2005 | 256 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 823 | 0.060 |
Why?
| | Cell Culture Techniques | 1 | 2007 | 343 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 2711 | 0.060 |
Why?
| | Gene Deletion | 1 | 2006 | 356 | 0.060 |
Why?
| | Protein Interaction Mapping | 1 | 2005 | 101 | 0.060 |
Why?
| | MAP Kinase Signaling System | 1 | 2006 | 276 | 0.060 |
Why?
| | Corticosterone | 1 | 2005 | 211 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2005 | 188 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 139 | 0.060 |
Why?
| | Computer Simulation | 1 | 2008 | 873 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2004 | 615 | 0.050 |
Why?
| | 1-Carboxyglutamic Acid | 1 | 1983 | 4 | 0.050 |
Why?
| | Male | 8 | 2019 | 55609 | 0.050 |
Why?
| | Arteriosclerosis | 1 | 1983 | 83 | 0.050 |
Why?
| | Glutamates | 1 | 1983 | 57 | 0.050 |
Why?
| | Heart Valves | 1 | 1983 | 41 | 0.050 |
Why?
| | Immune Sera | 1 | 2002 | 79 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 796 | 0.050 |
Why?
| | Phosphoserine | 1 | 2002 | 33 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2005 | 388 | 0.050 |
Why?
| | I-kappa B Kinase | 1 | 2002 | 50 | 0.050 |
Why?
| | Blood Proteins | 2 | 2011 | 231 | 0.050 |
Why?
| | Down-Regulation | 1 | 2004 | 594 | 0.050 |
Why?
| | Cytosol | 1 | 2002 | 208 | 0.050 |
Why?
| | Etoposide | 1 | 2002 | 148 | 0.050 |
Why?
| | Calcium-Binding Proteins | 1 | 1983 | 206 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 98 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2540 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 338 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 695 | 0.050 |
Why?
| | Dendritic Cells | 1 | 2004 | 435 | 0.050 |
Why?
| | Homeostasis | 1 | 2004 | 573 | 0.050 |
Why?
| | Thymocytes | 1 | 2020 | 28 | 0.040 |
Why?
| | NF-kappa B p50 Subunit | 3 | 1995 | 25 | 0.040 |
Why?
| | Calcinosis | 1 | 1983 | 242 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 89 | 0.040 |
Why?
| | Bone and Bones | 1 | 1983 | 279 | 0.040 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2020 | 56 | 0.040 |
Why?
| | Hematinics | 1 | 2019 | 18 | 0.040 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 27 | 0.040 |
Why?
| | Ionomycin | 1 | 1999 | 24 | 0.040 |
Why?
| | Complement C3-C5 Convertases | 1 | 2019 | 19 | 0.040 |
Why?
| | Fas Ligand Protein | 1 | 1999 | 57 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 2 | 1993 | 608 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2004 | 766 | 0.040 |
Why?
| | Hybridomas | 1 | 1999 | 230 | 0.040 |
Why?
| | Nanomedicine | 1 | 2019 | 28 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1998 | 47 | 0.040 |
Why?
| | 3T3 Cells | 1 | 1998 | 140 | 0.040 |
Why?
| | Gene Expression Regulation | 3 | 1993 | 2320 | 0.040 |
Why?
| | Durapatite | 1 | 1998 | 35 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2001 | 282 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1518 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 301 | 0.040 |
Why?
| | Lung Neoplasms | 2 | 2009 | 2177 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1998 | 164 | 0.040 |
Why?
| | Joint Diseases | 1 | 1998 | 59 | 0.040 |
Why?
| | Phosphorylation | 1 | 2002 | 1569 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2006 | 900 | 0.040 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1995 | 38 | 0.040 |
Why?
| | Brain | 1 | 1989 | 2371 | 0.040 |
Why?
| | Collectins | 1 | 2017 | 12 | 0.040 |
Why?
| | Cartilage | 1 | 2019 | 182 | 0.040 |
Why?
| | Binding Sites | 1 | 2000 | 1168 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2017 | 198 | 0.040 |
Why?
| | Antigen-Antibody Complex | 1 | 2017 | 84 | 0.040 |
Why?
| | Camptothecin | 1 | 2017 | 96 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2017 | 286 | 0.030 |
Why?
| | Drug Synergism | 2 | 1995 | 317 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2001 | 551 | 0.030 |
Why?
| | Proteins | 1 | 1983 | 908 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1998 | 329 | 0.030 |
Why?
| | Mannose-Binding Lectin | 1 | 2016 | 20 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1083 | 0.030 |
Why?
| | Particle Size | 1 | 2017 | 317 | 0.030 |
Why?
| | Surface Properties | 1 | 2017 | 387 | 0.030 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2017 | 181 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 1996 | 47 | 0.030 |
Why?
| | Cloning, Molecular | 3 | 2002 | 522 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 345 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 142 | 0.030 |
Why?
| | Middle Aged | 4 | 2019 | 26738 | 0.030 |
Why?
| | Cytoplasm | 2 | 1993 | 255 | 0.030 |
Why?
| | Viral Matrix Proteins | 1 | 1995 | 24 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 1996 | 151 | 0.030 |
Why?
| | Collagen | 1 | 2017 | 415 | 0.030 |
Why?
| | Mifepristone | 1 | 1995 | 60 | 0.030 |
Why?
| | Androgens | 1 | 1996 | 167 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 770 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 1995 | 93 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 1995 | 125 | 0.030 |
Why?
| | Fibroblasts | 1 | 1998 | 838 | 0.030 |
Why?
| | NF-kappa B p52 Subunit | 1 | 1993 | 1 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2012 | 8 | 0.030 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2012 | 14 | 0.030 |
Why?
| | Levodopa | 1 | 2012 | 23 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2001 | 2087 | 0.030 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2004 | 44 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 337 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 83 | 0.030 |
Why?
| | Protein Precursors | 1 | 1993 | 119 | 0.030 |
Why?
| | Pigmentation | 1 | 2012 | 55 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 192 | 0.020 |
Why?
| | Plasmids | 2 | 1992 | 343 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1637 | 0.020 |
Why?
| | Knee Joint | 1 | 2015 | 323 | 0.020 |
Why?
| | Female | 5 | 2019 | 59523 | 0.020 |
Why?
| | Rhodopsin | 1 | 2011 | 9 | 0.020 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2011 | 18 | 0.020 |
Why?
| | Administration, Ophthalmic | 1 | 2011 | 14 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2011 | 52 | 0.020 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2004 | 147 | 0.020 |
Why?
| | Indazoles | 1 | 2011 | 58 | 0.020 |
Why?
| | Ophthalmic Solutions | 1 | 2011 | 66 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 347 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2010 | 193 | 0.020 |
Why?
| | Vitreous Body | 1 | 2011 | 101 | 0.020 |
Why?
| | Antibody Formation | 1 | 1972 | 266 | 0.020 |
Why?
| | Interleukin-1 | 1 | 1995 | 966 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 314 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 304 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 412 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 260 | 0.020 |
Why?
| | Saxitoxin | 1 | 1989 | 3 | 0.020 |
Why?
| | Adult | 3 | 2019 | 30554 | 0.020 |
Why?
| | Cell Membrane | 1 | 2012 | 680 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2011 | 347 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1993 | 1131 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 1988 | 94 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 923 | 0.020 |
Why?
| | Dinoprostone | 1 | 2009 | 184 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1021 | 0.020 |
Why?
| | Retinal Ganglion Cells | 1 | 1988 | 92 | 0.020 |
Why?
| | Up-Regulation | 1 | 2010 | 808 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 869 | 0.020 |
Why?
| | DNA | 1 | 1993 | 1352 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 523 | 0.020 |
Why?
| | Saccharomyces | 1 | 1986 | 7 | 0.020 |
Why?
| | Retina | 1 | 1988 | 263 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 1188 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2009 | 676 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2001 | 3256 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2187 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 2 | 1996 | 138 | 0.010 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2004 | 58 | 0.010 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 150 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-rel | 2 | 1993 | 8 | 0.010 |
Why?
| | Osteocalcin | 1 | 1983 | 34 | 0.010 |
Why?
| | Vitamin K | 1 | 1983 | 42 | 0.010 |
Why?
| | Blood Glucose | 1 | 2011 | 1829 | 0.010 |
Why?
| | Mice, Inbred NOD | 1 | 2004 | 555 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 26 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 40 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6116 | 0.010 |
Why?
| | Rats, Inbred BB | 1 | 2001 | 5 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2002 | 171 | 0.010 |
Why?
| | Thy-1 Antigens | 1 | 2001 | 11 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2001 | 49 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2001 | 91 | 0.010 |
Why?
| | Chromosome Segregation | 1 | 2001 | 36 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2001 | 69 | 0.010 |
Why?
| | Lymphopenia | 1 | 2001 | 49 | 0.010 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2001 | 46 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2001 | 111 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2001 | 274 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2001 | 174 | 0.010 |
Why?
| | Vitamin D | 1 | 1983 | 341 | 0.010 |
Why?
| | Aging | 1 | 1989 | 1618 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 309 | 0.010 |
Why?
| | Cell Cycle | 1 | 2001 | 542 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 750 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 577 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 869 | 0.010 |
Why?
| | Complement C4 | 1 | 1996 | 25 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1996 | 70 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2001 | 2218 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 345 | 0.010 |
Why?
| | Insulin | 1 | 2004 | 2080 | 0.010 |
Why?
| | Transcription Factor RelB | 1 | 1992 | 4 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 1972 | 29 | 0.010 |
Why?
| | Agar | 1 | 1972 | 11 | 0.010 |
Why?
| | Splenomegaly | 1 | 1972 | 17 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 1972 | 17 | 0.010 |
Why?
| | Culture Techniques | 1 | 1972 | 78 | 0.010 |
Why?
| | Vinblastine | 1 | 1972 | 63 | 0.010 |
Why?
| | Mutagenesis | 1 | 1992 | 168 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1992 | 397 | 0.010 |
Why?
| | Chickens | 1 | 1972 | 177 | 0.010 |
Why?
| | Clone Cells | 1 | 1972 | 247 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1992 | 187 | 0.010 |
Why?
| | Organ Size | 1 | 1972 | 436 | 0.010 |
Why?
| | Rabbits | 1 | 1972 | 733 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1862 | 0.010 |
Why?
| | Antigens | 1 | 1972 | 318 | 0.010 |
Why?
| | Cell Division | 1 | 1972 | 758 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 487 | 0.010 |
Why?
| | Sheep | 1 | 1972 | 764 | 0.010 |
Why?
| | Child, Preschool | 1 | 1983 | 9119 | 0.010 |
Why?
| | Cattle | 1 | 1972 | 920 | 0.010 |
Why?
| | Erythrocytes | 1 | 1972 | 591 | 0.000 |
Why?
| | DNA, Fungal | 1 | 1986 | 69 | 0.000 |
Why?
| | Aged | 1 | 1983 | 19074 | 0.000 |
Why?
| | Immunohistochemistry | 1 | 1988 | 1629 | 0.000 |
Why?
| | Child | 1 | 1983 | 18422 | 0.000 |
Why?
|
|
Scheinman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|